Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03615222 · ClinicalTrials.gov registry record

Impact of Modifiable Psychosocial Factors on Veterans' Long-term Trajectories of Functioning and Quality of Life

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
377
Enrollment target

NCT03615222: Completed study, sponsored by VA Office of Research and Development.

NCT03615222 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 377 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03615222 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
377 participants
Enrollment target

Study Summary

This study is Phase 3 of Project SERVE (Study Evaluating Returning Veterans' Experiences). Through two prior phases, SERVE has followed a cohort of post-9/11 Veterans since 2010 and has identified numerous risk and protective factors. SERVE's overall objective is to understand and improve the long-term functional outcomes of post-9/11 Veterans. Consistent with the investigators' conceptual model, the central hypothesis is that psychological flexibility and other trans-diagnostic treatment targets mediate the effects of the most common mental and physical wounds of war on long-term functioning and self-directed violence (i.e., suicide risk). Thus, integrated interventions specifically designed to improve functioning associated with these conditions are most likely to promote long-term recovery among the most impaired Veterans. The investigators will test the central hypothesis and accomplish the overall objective by pursuing the following specific aims: Aim 1: Identify treatment targets that prospectively predict functional disability, family functioning and self-directed violence (SDV) in post-9/11 Veterans with PTSD, depression, chronic pain, TBI, and/or AUD. To achieve this aim, the investigators will follow 500 Veterans for 2 years in order to prospectively evaluate the impact of several novel, treatment-relevant factors on functional disability and SDV over time. H1: Novel factors (mindfulness, perceived burdensomeness, thwarted belongingness, and moral injury) along with established treatment targets (psychological flexibility, self-compassion, and emotion regulation) will prospectively predict functional disability and SDV after accounting for covariates.

Trial Details

FieldValue
Enrollment Target 377 participants
Start Date 2018-10-01
Est. Completion 2023-09-30

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03615222

The ClinicalTrials.gov registry entry for NCT03615222 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 377 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03615222 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03615222 about?

NCT03615222 is a clinical study titled "Impact of Modifiable Psychosocial Factors on Veterans' Long-term Trajectories of Functioning and Quality of Life". This study is Phase 3 of Project SERVE (Study Evaluating Returning Veterans' Experiences). Through two prior phases, SERVE has followed a cohort of post-9/11 Veterans since 2010 and has identified numerous risk and protective factors. SERVE's overall objective is to understand and improve the long-t...

What is the current status of trial NCT03615222?

This trial is currently completed. The enrollment target is 377 participants. The study started on 2018-10-01. Estimated completion is 2023-09-30.

Who is sponsoring clinical trial NCT03615222?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.